NCT07128472 - Evaluation of IL 12B Genetic Polymorphism (rs3213094) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

January 20, 2026

Study Completion Date

February 1, 2026

Conditions

Psoriasis

Interventions

DRUG

Humira

Assess the response of psoriasis and psoriatic arthritis to Humira and also Assessing the pharmacogenetic association between IL 12B genetic polymorphism (rs3213094) in psoriatic and psoriatic arthritis patients taking Humira.

Trial Locations (1)

Unknown

RECRUITING

Qina University hospital, South Valley University Hospital, Qina

All Listed Sponsors

lead

South Valley University

OTHER